Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C.

× No keyword cloud information.

15 in total

1. Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines.

Authors: Moon Seok Choi; Byung Chul Yoo
Journal: Gut Liver Date: 2010-03-25 Impact factor: 4.519

2. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.

Authors: Xiu-Ping Zhang; Kang Wang; Xu-Biao Wei; Le-Qun Li; Hui-Chuan Sun; Tian-Fu Wen; Zong-Tao Chai; Zhen-Hua Chen; Jie Shi; Wei-Xing Guo; Dong Xie; Wen-Ming Cong; Meng-Chao Wu; Wan Yee Lau; Shu-Qun Cheng
Journal: Oncologist Date: 2019-05-28

3. Misperceptions among patients with chronic hepatitis B in Singapore.

Authors: Chun-Tao Wai; Belinda Mak; Winnie Chua; Mei-Hua Tan; Seline Ng; Amelia Cheok; Mee-Lian Wong; Seng-Gee Lim
Journal: World J Gastroenterol Date: 2005-08-28 Impact factor: 5.742

4. Towards a rational treatment strategy for chronic hepatitis B.

Authors: Yun-Fan Liaw
Journal: Hepatol Int Date: 2007-06-06 Impact factor: 6.047

Review 5. KASL clinical practice guidelines: management of chronic hepatitis B.

Authors:
Journal: Clin Mol Hepatol Date: 2016-03-28

6. KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors:
Journal: Clin Mol Hepatol Date: 2012-06-26

Review 7. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability.

Authors: David L Murdoch; Karen Goa; David P Figgitt
Journal: Drugs Date: 2003 Impact factor: 9.546

8. Combined two-dose hepatitis A and B vaccine (AmBirix).

Authors: Blair Jarvis; David P Figgitt
Journal: Drugs Date: 2003 Impact factor: 9.546

9. CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis.

Authors: Haijun Huang; Tiangang Wu; Jian Mao; Yongxing Fang; Jiajie Zhang; Lihua Wu; Shu Zheng; Biaoyang Lin; Hongying Pan
Journal: OMICS Date: 2015-06

Review 10. Current antiviral therapy for chronic hepatitis B.

Authors: Young-Suk Lim; Dong Jin Suh
Journal: J Korean Med Sci Date: 2004-08 Impact factor: 2.153